| PERIOD ENDING | 31-Mar-05 |
| Total Revenue | 5,151 |
| Cost of Revenue | 1,519 |
|
| Gross Profit | 3,632 |
|
| Operating Expenses |
| Research Development | 662 |
| Selling General and Administrative | 2,638 |
| Non Recurring |
-
|
| Others |
-
|
| |
| Total Operating Expenses |
-
|
|
|
| Operating Income or Loss | 332 |
|
| Income from Continuing Operations |
| Total Other Income/Expenses Net | 94 |
| Earnings Before Interest And Taxes | 426 |
| Interest Expense |
-
|
| Income Before Tax | 426 |
| Income Tax Expense | 123 |
| Minority Interest |
-
|
| |
| Net Income From Continuing Ops | 303 |
|
| Non-recurring Events |
| Discontinued Operations |
-
|
| Extraordinary Items |
-
|
| Effect Of Accounting Changes |
-
|
| Other Items |
-
|
|
|
| Net Income | 303 |
| Preferred Stock And Other Adjustments |
-
|
|
| Net Income Applicable To Common Shares | $303 |
0.07% Nasdaq 
Income Statement
